1 of 6 INKT cell therapies in the world.
Preclinical suggests INKT will supersede CAR-T.
You probably don’t need to understand much more than those two points, this is going to be enormous.
Spark Plus - Arovella Desk Note, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.010(6.06%) |
Mkt cap ! $183.9M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.8¢ | 16.5¢ | $767.1K | 4.540M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 267648 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 355573 | 3 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |